| 6301 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
19 |
| 6302 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
68 |
| 6303 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
62 |
| 6304 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
67 |
| 6305 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia; Myeloproliferative Syndrome
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
62 |
| 6306 |
Apheresis |
Autologous
|
Amyloidosis
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
72 |
| 6307 |
Apheresis |
Autologous
|
Amyloidosis
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
75 |
| 6308 |
Apheresis |
Allogeneic
|
Aplastic Anemia
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
61 |
| 6309 |
Apheresis |
Autologous
|
Apoplexy
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
3 |
| 6310 |
Apheresis |
Allogeneic
|
Atypical Chronic Myeloid Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
58 |
| 6311 |
Apheresis |
Allogeneic
|
B-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
41 |
| 6312 |
Apheresis |
Allogeneic
|
B-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
50 |
| 6313 |
Apheresis |
Allogeneic
|
B-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
34 |
| 6314 |
Apheresis |
Allogeneic
|
B-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
34 |
| 6315 |
Apheresis |
Allogeneic
|
B-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
52 |
| 6316 |
Apheresis |
Allogeneic
|
B-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
46 |
| 6317 |
Apheresis |
Allogeneic
|
B-Cell Chronic Lymphoblastic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
65 |
| 6318 |
Apheresis |
Autologous
|
B-Cell Non-Hodgkin Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
69 |
| 6319 |
Apheresis |
Autologous
|
B-Cell Non-Hodgkin Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
43 |
| 6320 |
Apheresis |
Allogeneic
|
B-Cell Non-Hodgkin Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
66 |
| 6321 |
Apheresis |
Allogeneic
|
B-Cell Non-Hodgkin Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
32 |
| 6322 |
Apheresis |
Allogeneic
|
Blastic Nk Cell Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
65 |
| 6323 |
Apheresis |
Allogeneic
|
Chronic Granulomatous Disease
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
15 |
| 6324 |
Apheresis |
Allogeneic
|
Chronic Granulomatous Disease
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
2 |
| 6325 |
Apheresis |
Allogeneic
|
Chronic Lymphocytic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
49 |
| 6326 |
Apheresis |
Allogeneic
|
Chronic Lymphocytic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
38 |
| 6327 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
63 |
| 6328 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
48 |
| 6329 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
25 |
| 6330 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
41 |
| 6331 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
44 |
| 6332 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
54 |
| 6333 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
39 |
| 6334 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
63 |
| 6335 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
56 |
| 6336 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
71 |
| 6337 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
51 |
| 6338 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
67 |
| 6339 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
67 |
| 6340 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
49 |
| 6341 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
60 |
| 6342 |
Apheresis |
Allogeneic
|
Diffuse Large B-Cell Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
54 |
| 6343 |
Apheresis |
Autologous
|
Diffuse Large B-Cell Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
71 |
| 6344 |
Apheresis |
Autologous
|
Diffuse Large B-Cell Lymphoma – Relapse
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
71 |
| 6345 |
Apheresis |
Allogeneic
|
Fanconi Anemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
9 |
| 6346 |
Apheresis |
Allogeneic
|
Follicular Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
44 |
| 6347 |
Apheresis |
Autologous
|
Follicular Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
65 |
| 6348 |
Apheresis |
Allogeneic
|
Follicular Lymphoma (Non-Hodgkin Lymphoma)
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
56 |
| 6349 |
Apheresis |
Autologous
|
Germ Cell Tumor
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
23 |
| 6350 |
Apheresis |
Autologous
|
Germ Cell Tumor
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
31 |
| 6351 |
Apheresis |
Allogeneic
|
Hodgkin Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
38 |
| 6352 |
Apheresis |
Allogeneic
|
Hodgkin Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
27 |
| 6353 |
Apheresis |
Allogeneic
|
Hypoplastic Mds-Eb2 With Incipient Saml
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
63 |
| 6354 |
Apheresis |
Autologous
|
Large B-Cell Non-Hodgkin-Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
66 |
| 6355 |
Apheresis |
Allogeneic
|
Leukemia
|
Hematology
|
2018
|
Standard Therapy
|
Poland
|
34 |
| 6356 |
Apheresis |
Allogeneic
|
Lymphomatoid Granulomatosis
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
36 |
| 6357 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
66 |
| 6358 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
64 |
| 6359 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
44 |
| 6360 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
66 |
| 6361 |
Apheresis |
Autologous
|
Morbus Hodgkin
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
65 |
| 6362 |
Apheresis |
Autologous
|
Morbus Hodgkin
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
31 |
| 6363 |
Apheresis |
Allogeneic
|
Morbus Hodgkin-Relapse
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
35 |
| 6364 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
67 |
| 6365 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
61 |
| 6366 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
61 |
| 6367 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
66 |
| 6368 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
57 |
| 6369 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
53 |
| 6370 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
57 |
| 6371 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
65 |
| 6372 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
47 |
| 6373 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
60 |
| 6374 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
66 |
| 6375 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
62 |
| 6376 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
67 |
| 6377 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
65 |
| 6378 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
54 |
| 6379 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
58 |
| 6380 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
51 |
| 6381 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
69 |
| 6382 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
52 |
| 6383 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
62 |
| 6384 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
62 |
| 6385 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
65 |
| 6386 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
62 |
| 6387 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
64 |
| 6388 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
63 |
| 6389 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
55 |
| 6390 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
60 |
| 6391 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
61 |
| 6392 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
62 |
| 6393 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
64 |
| 6394 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
55 |
| 6395 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
65 |
| 6396 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
64 |
| 6397 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
52 |
| 6398 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
61 |
| 6399 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
69 |
| 6400 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2018
|
Standard Therapy
|
Germany
|
73 |